Navigation Links
NYSCF - Robertson investigator publishes research to better understand pluripotent stem cells

NEW YORK CITY (March 7, 2011) Paul Tesar, PhD, of Case Western Reserve University, a member of the inaugural class of The New York Stem Cell Foundation Robertson Investigators, published his research on the ability to isolate epiblast stem cells from preimplantation mouse embryos. This research enhances our understanding of the many forms of pluriportent stem cells that scientists use for researching so many debilitating diseases.

"I think that this paper will change the way people think about what human ES cells represent from a developmental perspective," said Dr. Kevin Eggan, NYSCF Chief Scientific Officer and Associate Professor of Stem Cell and Regenerative Biology at the Harvard Stem Cell Institute.

The study, "Isolation of Epiblast Stem Cells from Preimplantation Mouse Embryos", was published in Cell Stem Cell on March 4th, 2011. In 2007, Dr. Tesar was the lead author on the study that first isolated mouse epiblast stem cells from post-implantation mouse embryos when he was a graduate student in the NIH-Oxford Biomedical Research Scholars program, splitting his time between the two institutions.

Dr. Tesar's research focuses on understanding how different cell types in the nervous system are initially formed during development and how they are maintained throughout adult life. "My hope is that by understanding these basic questions we will be able to prevent or repair damage caused by disease, aging, and injury," said Dr. Tesar. "Research in my lab has the potential to impact a number of devastating neurodegenerative and mental health conditions such as Parkinson's disease, ALS, Hungtington's disease, autism, and multiple sclerosis."

Research in the Tesar lab aims to develop new strategies to restore function in patients afflicted with myelin-based disorders. Loss of myelin results in an impairment in the body's ability to send signals along the neurons. "Dr. Tesar is a wonderful young scientist and the research he is doing will provide significant advances for patients with myelin-based diseases," said Susan L. Solomon, Chief Executive Officer of The New York Stem Cell Foundation. "We are delighted to support Dr. Tesar's critical research, which has the potential to accelerate the path from bench to bedside. He is well on his way to a successful career."

NYSCF named Dr. Tesar as one of six NYSCF Investigators at its Fifth Annual Translational Stem Cell Research Conference last October as an expansion of its ongoing efforts to promote the next generation of stem cell scientists. Each of the NYSCF Robertson Investigators receive $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms. This funding will support the most promising and creative scientists whose research projects have the potential to accelerate the path from bench to bedside.


Contact: Nadine Woloshin
New York Stem Cell Foundation

Related medicine news :

1. SUNZ Insurance Company Selects Scott Robertson as President
2. Scott & White Healthcare pathologist is co-investigator on breast cancer study
3. SEBM Young Investigator Awards for 2010
4. BUSM researcher receives prestigious young investigator award
5. Investigators examine colorectal cancer screening methods among diverse populations
6. University of Utah afib specialist, Marcos Daccarett, M.D., wins Young Investigator Award
7. UT Southwestern investigators perform head-to-head comparison of incontinence treatments
8. BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation
9. Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators
10. Investigators identify gene associated with kidney disease in African-American population
11. SWOG names 5 cancer researchers outstanding Young Investigators
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: